Contact BioPharm International Sales
BioPharm International Sales Office
485F US Highway 1 South
Suite 210
Iselin, NJ 08830-3009
Phone: 732.596.0276
Fax: 732.647.1235
Send press releases to: [email protected]
Sales Team
Mike Tracey
Group Publisher
Phone: 732-346-3027
[email protected]
Steve Hermer
National Sales Manager
Phone: 619.218.4028
[email protected]
Scott Vail
East Coast Sales Manager
Phone: 973.538.3588
[email protected]
Joanne Capone
Insertion Orders
Phone: 732.346.3031
Fax: 732.596.0012
[email protected]
EUROPE
Address:
Advanstar Communications (UK) Ltd
Hinderton Point
Lloyd Drive
Chestershire Oaks
Chester, CH65 9HQ, UK
Sales Team:
Linda Hewitt
European Sales Manager
tel. +44 (0)015 135 33647
[email protected]
Market Development
Direct Mail Lists
Tamara Phillips
tel. 888.736.8547, ext. 2773
[email protected]
Reprints
Wright’s Media
Phone: (281) 419.5725 ext.104
Fax: (281) 419.5712
Toll Free: (877) 652.5295
Permissions and International Licensing
Maureen Cannon
tel. 440.891.2742
or 800.225.4569 ext 2742
fax 440.891.2650
[email protected]
| ||||||||||||||||||
| ||||||||||||||||||
|
|---|
|
Current Issue
Particle Analysis Techniques Help Meet Regulatory Requirements
An increase in biologics raises awareness of particle generation and its role in negative patient outcomes.
A Novel Metric for Continuous Improvement During Stage Three
How statistical methods and novel indices can be used to monitor and benchmark variability, to guide continuous improvement programs.
Managing Residual Impurities During Downstream Processing
Increased understanding of potential impurities has spurred efforts to standardize monitoring procedures.
Outsourcing
Contract Manufacturing Through the Years
How has the bio/pharmaceutical contract manufacturing industry evolved and changed over the years and what does the future hold?
CordenPharma, GE Healthcare Partner to Speed Development
GE Healthcare’s Dharmacon business and CordenPharma contract manufacturing enter a strategic collaboration to accelerate the oligonucleotide development process.
Lonza Completes Capsugel Acquisition
A $5.5 billion acquisition brings Capsugel’s oral dosage delivery capabilities to Lonza’s portfolio.
Patheon Invests $45 Million in Facilities
Patheon will add spray drying, sterile manufacturing, and packaging capabilities to four facilities.
Standards/Regulations
Woodcock Sees Future for Precision Medicine
In an FDAVoice blog post, the CDER director highlighted two recent scientific advances.
Data Integrity and Quality Problems Found at China Facility
FDA sent a warning letter to Shandong Analysis and Test Center for CGMP violations including data integrity issues and insufficient testing procedures.
EMA Recommends Restrictions on Multiple Sclerosis Medicine
The agency’s Pharmacovigilance Risk Assessment Committee made recommendations on the risk of multiple sclerosis treatments, injectable methylprednisolone medicines, and the use of gadolinium contrast agents.
Webcasts
Sponsored Links
